MedX Health closes $834K first tranche

Mississauga, ON (pcJ News Briefs) – MedX Health Corp. (TSX-V: MDX) has closed, effective April 21, 2017, first tranche of previously announced $3 million brokered private placement, issuing 6,948,333 units at $0.12 per unit for gross proceeds of $833,800.

Each unit consists of one common share and one warrant entitling the holder to purchase one additional common share during the period expiring April 21, 2020, at $0.20 per share.

Wildlaw Capital Markets Inc. acts as agent for the offering.

Upon closing, MedX Health has 104,639,494 shares outstanding.

MedX Health Corp. is a medical device company focused on skin cancer with its SIAscopy technology.

photo credit: MedX Health

CPE Media News

Private Capital Journal, a service of CPE Media News, provides Canada's complete private capital (angel, venture capital, private equity, private/exempt), public financing, M&A, IPO/RTO news and intelligence.